Showcasing Preliminary Results from a Phase I/II, FIH Study of MGC018 in Patients with Advanced Solid Tumours

Time: 11:00 am
day: Track C - Day 2


  • Examine B7H3 as a target for an ADC with a duocarmycin payload
  • Presenting a safety overview from Phase 1
  • Analyse efficacy from preliminary evidence of a Phase 1